title: Developments toward a recombinant pertussis vaccine.
authors.affiliation: Amgen Inc., Thousand Oaks, CA 91320.
authors.forename: W N
authors.initials: WN
authors.lastname: Burnette
authors.forename: D W
authors.initials: DW
authors.lastname: Whiteley
authors.forename: V L
authors.initials: VL
authors.lastname: Mar
authors.forename: D L
authors.initials: DL
authors.lastname: Burns
authors.forename: H R
authors.initials: HR
authors.lastname: Kaslow
authors.forename: W
authors.initials: W
authors.lastname: Cieplak
authors.forename: J M
authors.initials: JM
authors.lastname: Keith
authors.forename: T D
authors.initials: TD
authors.lastname: Bartley
mesh_terms: D003001:Cloning, Molecular; D006801:Humans; D010567:Pertussis Vaccine / Q000276:immunology; D011487:Protein Conformation; D014612:Vaccines / Q000276:immunology; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D010566:Virulence Factors, Bordetella / Q000235:genetics / Q000276:immunology
chemical_list: D010567:Pertussis Vaccine; D014612:Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella